Cargando...
Ex vivo susceptibility to new antimalarial agents differs among human-infecting Plasmodium species
Several promising antimalarial drugs are currently being tested in human trials, such as artefenomel, cipargamin, ferroquine and ganaplacide. Many of these compounds were identified using high throughput screens against a single species of human malaria, Plasmodium falciparum, under the assumption t...
Guardado en:
| Publicado en: | Int J Parasitol Drugs Drug Resist |
|---|---|
| Autores principales: | , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Elsevier
2021
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8327131/ https://ncbi.nlm.nih.gov/pubmed/34315108 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijpddr.2021.07.002 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|